-

nihao guest [ sign in / register ]
2026-11-21 18:49:38


Meeker JR, Price AM, Martin E, Vaughn I, Wernli KJ. Influenza B Circulation and Vaccine Effectiveness Against Medically Attended Outpatient Influenza B Illness, United States, 2016-17 Through 2024-25. J Infect Dis. 2026 Oct 31:jiag538
submited by kickingbird at Nov, 2, 2026 21:39 PM from J Infect Dis. 2026 Oct 31:jiag538

Background: Influenza B vaccine effectiveness (VE) has varied by season, lineage, antigenic drift, and vaccine composition. After B/Yamagata detection ceased globally, trivalent vaccines containing B/Victoria were reintroduced in 2024-25. We evaluated influenza B circulation and VE across eight analyzed seasons spanning this transition.

Methods: Ambulatory patients aged ≥6 months with acute respiratory illness were enrolled at U.S. Flu VE Network sites during eight influenza seasons from 2016-17 through 2024-25; 2020-21 was excluded because influenza circulation was negligible. Participants were tested by RT-PCR. Lineage-specific VE was estimated using a test-negative design and logistic regression adjusted for age, sex, race/ethnicity, calendar time, and study site. VE was reported for season-lineage strata with ≥50 influenza B cases.

Results: Among 65,773 participants, 3,629 influenza B cases were included in lineage-specific VE analyses (1,507 B/Yamagata; 2,122 B/Victoria). Six of 10 season-lineage strata met the reporting threshold. B/Victoria VE was 58% (95% CI, 28%-77%) in 2016-17, 51% (43%-57%) in 2019-20, 78% (71%-84%) in 2023-24, and 39% (14%-56%) in 2024-25. B/Yamagata VE was 55% (46%-63%) in 2016-17 and 49% (40%-56%) in 2017-18.

Conclusions: Influenza vaccines protected against medically attended outpatient influenza B illness, although VE varied by season. Continued VE monitoring and genetic surveillance are needed to detect emerging influenza B viruses and inform vaccine strain selection.

See Also:

Latest articles in those days:

[Go Top]    [Close Window]

Related Pages:
Learn about the flu news, articles, events and more
Subscribe to the weekly F.I.C newsletter!


  

Site map  |   Contact us  |  Term of use  |  FAQs |  粤ICP备10094839号-1
Copyright ©www.flu.org.cn. 2004-2026. All Rights Reserved. Powered by FIC 4.0.1
  Email:webmaster@flu.org.cn